First Report Managed Care - Home

The FDA has approved Yescarta for the treatment of  non-Hodgkin lymphoma, the second CAR-T gene therapy approved in the United States. | Read More
A poster presented at AMCP Nexus 2017 found that implementation of a value-based plan design did not significantly impact costs compared to standard benefit design. | Read More
Aimee Tharaldson, PharmD, from Express Scripts outlined the upcoming specialty pharmacy drugs that could significantly impact pharmacy spending in 2018. | Read More
One day after signaling that he was supportive of the ACA stabilization deal reached by Senators Alexander and Murray, President Trump publicly withdrew his support for the bill. | Read More